Gene · 657
Papers3,264
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
721 to 740 of 3,264
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Incidental germline findings during molecular profiling of tumor tissues for precision oncology: molecular survey and methodological obstacles. | J Transl Med | 2022 | 35033101 | PubTator, text mining | PubMed |
| Uncoupling the BMP receptor antagonist function from the WNT agonist function of R-spondin 2 using the inhibitory peptide dendrimer RWd. | J Biol Chem | 2022 | 35032551 | PubTator, text mining | PubMed |
| Comprehensive patient-level classification and quantification of driver events in TCGA PanCanAtlas cohorts. | PLoS Genet | 2022 | 35030162 | PubTator, text mining | PubMed |
| The repertoire of germline variants in patients with early-onset rectal cancer. | Cancer Commun (Lond) | 2022 | 35029067 | PubTator, text mining | PubMed |
| SMURF2 phosphorylation at Thr249 modifies glioma stemness and tumorigenicity by regulating TGF-β receptor stability. | Commun Biol | 2022 | 35017630 | PubTator, text mining | PubMed |
| Comprehensive characterization of CRC with germline mutations reveals a distinct somatic mutational landscape and elevated cancer risk in the Chinese population. | Cancer Biol Med | 2022 | 35014770 | PubTator, text mining | PubMed |
| NETME: on-the-fly knowledge network construction from biomedical literature. | Appl Netw Sci | 2022 | 35013714 | PubTator, text mining | PubMed |
| Structures of activin ligand traps using natural sets of type I and type II TGFβ receptors. | iScience | 2022 | 35005539 | PubTator, text mining | PubMed |
| Chemoproteomic Analysis of Microbiota Metabolite-Protein Targets and Mechanisms. | Biochemistry | 2022 | 34989554 | PubTator, text mining | PubMed |
| Changes in progenitors and differentiated epithelial cells of neonatal piglets. | Anim Nutr | 2022 | 34988308 | PubTator, text mining | PubMed |
| COL17A1 germline variant p.Ser1029Ala and mucosal malignant melanoma: An autopsy study. | Mol Clin Oncol | 2022 | 34987801 | PubTator, text mining | PubMed |
| Multilocus Inherited Neoplasia Allele Syndrome (MINAS): an update. | Eur J Hum Genet | 2022 | 34983940 | PubTator, text mining | PubMed |
| Medical manifestations and health care utilization among adult MyCode participants with neurodevelopmental psychiatric copy number variants. | Genet Med | 2022 | 34906480 | PubTator, text mining | PubMed |
| Application of Multigene Panel Testing in Patients With High Risk for Hereditary Colorectal Cancer: A Descriptive Report Focused on Genotype-Phenotype Correlation. | Dis Colon Rectum | 2022 | 34897210 | PubTator, text mining | PubMed |
| Endothelial k-RasV12 Expression Induces Capillary Deficiency Attributable to Marked Tube Network Expansion Coupled to Reduced Pericytes and Basement Membranes. | Arterioscler Thromb Vasc Biol | 2022 | 34879709 | PubTator, text mining | PubMed |
| 30 year experience of index case identification and outcomes of cascade testing in high-risk breast and colorectal cancer predisposition genes. | Eur J Hum Genet | 2022 | 34866136 | PubTator, text mining | PubMed |
| SMAD4 mutations do not preclude epithelial-mesenchymal transition in colorectal cancer. | Oncogene | 2022 | 34857888 | PubTator, text mining | PubMed |
| Insights into in vivo follicle formation: a review of in vitro systems. | Histochem Cell Biol | 2022 | 34846577 | PubTator, text mining | PubMed |
| Identification of liver-derived bone morphogenetic protein (BMP)-9 as a potential new candidate for treatment of colorectal cancer. | J Cell Mol Med | 2022 | 34841646 | PubTator, text mining | PubMed |
| How many is too many? Polyposis syndromes and what to do next. | Curr Opin Gastroenterol | 2022 | 34839308 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/657/papers?page=37